Secretome Therapeutics is currently preparing an open-label, multiple ascending dose phase 1 study to assess STM-01 in patients with HFpEF. The Food and Drug Administration (FDA) has granted Fast ...
Objectives: To determine the cardiovascular tolerance of clonidine used as a first-line sedative after cardiac surgery in small infants. Design: Retrospective chart review. Setting: A tertiary and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results